Dexmedetomidine Use for Sedation in Patients Submitted to Tracheal Surgery

Postoperative Sedation Clinical Trial

Official title:
Efficacy and Safety of Dexmedetomidine Sedation in Spontaneous Breathing Patients After Tracheal Surgery

Status Completed

Clinical Trial Summary

Patients undergoing tracheal resection and reconstruction surgery are enrolled in this prospective observational pilot study to evaluate dexmedetomidine-based sedation after tracheal surgery in an Intensive Care Unit (ICU). Patients remain electively intubated with an uncuffed nasal endotracheal tube, awake and exhibit spontaneous breathing The neck was maintained in flexion through chin-to-chest sutures. Infusion of dexmedetomidine was started from a dosage of 0.7 μg kg-1 h-1 followed by dose titration to the target level of the sedation Richmond Agitation Sedation Scale, (RASS) score -1/-2 using a dose range of 0.2-1.4 μg kg-1 h-1.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Postoperative Sedation

Clinical Trial Details

NCT number	NCT03723538
Study type	Observational
Source	University of Roma La Sapienza
Contact
Status	Completed
Phase
Start date	February 1, 2018
Completion date	August 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00393003` - Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index	Phase 4
Completed	`NCT00125398` - GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting	Phase 2
Completed	`NCT01507363` - Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)	Phase 4